NZ562064A - Polymeric micelles for drug delivery - Google Patents
Polymeric micelles for drug deliveryInfo
- Publication number
- NZ562064A NZ562064A NZ562064A NZ56206406A NZ562064A NZ 562064 A NZ562064 A NZ 562064A NZ 562064 A NZ562064 A NZ 562064A NZ 56206406 A NZ56206406 A NZ 56206406A NZ 562064 A NZ562064 A NZ 562064A
- Authority
- NZ
- New Zealand
- Prior art keywords
- chain
- group
- nitrogen
- protected
- optionally substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
- A61K47/551—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/40—Polyamides containing oxygen in the form of ether groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/028—Polyamidoamines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Psychiatry (AREA)
- Nanotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Immunology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66726005P | 2005-04-01 | 2005-04-01 | |
| US74178005P | 2005-12-01 | 2005-12-01 | |
| PCT/US2006/012382 WO2006107903A2 (en) | 2005-04-01 | 2006-04-03 | Polymeric micelles for drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ562064A true NZ562064A (en) | 2011-03-31 |
Family
ID=36951510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ562064A NZ562064A (en) | 2005-04-01 | 2006-04-03 | Polymeric micelles for drug delivery |
Country Status (13)
| Country | Link |
|---|---|
| US (6) | US7638558B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1907444B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4390845B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101288729B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE440117T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006231452B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2603853C (cg-RX-API-DMAC7.html) |
| DE (1) | DE602006008625D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2332062T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL186254A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007012157A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ562064A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006107903A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (208)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080281041A1 (en) | 1999-06-07 | 2008-11-13 | Rozema David B | Reversibly Masked Polymers |
| US8008355B2 (en) * | 2002-03-11 | 2011-08-30 | Roche Madison Inc. | Endosomolytic poly(vinyl ether) polymers |
| US8138383B2 (en) * | 2002-03-11 | 2012-03-20 | Arrowhead Madison Inc. | Membrane active heteropolymers |
| AU2003230761A1 (en) * | 2002-03-29 | 2003-10-13 | Abbott Laboratories | Polymeric micelle formulations of hydrophobic compounds and methods |
| AU2004273986B2 (en) | 2003-09-15 | 2010-04-22 | Nanopharmaceuticals Llc | Thyroid hormone analogs and methods of use in angiogenesis |
| US8668926B1 (en) | 2003-09-15 | 2014-03-11 | Shaker A. Mousa | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| US9198887B2 (en) | 2003-09-15 | 2015-12-01 | Nanopharmaceuticals Llc | Thyroid hormone analogs and methods of use |
| WO2005067517A2 (en) * | 2004-01-02 | 2005-07-28 | Wisconsin Alumni Research Foundation | Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers |
| EP1833958A4 (en) * | 2005-01-04 | 2009-01-14 | Intezyne Technologies Inc | SYNTHESIS OF HYBRID BLOCK COPOLYMERS AND USES THEREOF |
| US9498536B2 (en) | 2005-09-15 | 2016-11-22 | Nanopharmaceuticals Llc | Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders |
| US10130686B2 (en) | 2005-09-15 | 2018-11-20 | Nanopharmaceuticals Llc | Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders |
| WO2007035612A2 (en) | 2005-09-16 | 2007-03-29 | Ordway Research Institute, Inc. | Polyphenol conjugates as rgd-binding compounds and methods of use |
| US7560588B2 (en) | 2006-04-27 | 2009-07-14 | Intezyne Technologies, Inc. | Poly(ethylene glycol) containing chemically disparate endgroups |
| US8212083B2 (en) | 2006-04-27 | 2012-07-03 | Intezyne Technologies, Inc. | Heterobifunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof |
| US20080035667A1 (en) * | 2006-06-07 | 2008-02-14 | Osg Norwich Pharmaceuticals, Inc. | Liquid delivery system |
| WO2008005509A2 (en) * | 2006-07-06 | 2008-01-10 | Massachusetts Institute Of Technology | Methods and compositions for altering biological surfaces |
| WO2008006097A2 (en) * | 2006-07-07 | 2008-01-10 | Intezyne Technologies Llc | Covalent modification of metal surfaces |
| CN101500548A (zh) * | 2006-08-18 | 2009-08-05 | 弗·哈夫曼-拉罗切有限公司 | 用于体内递送多核苷酸的多缀合物 |
| US8188046B2 (en) | 2006-10-16 | 2012-05-29 | University Of South Florida | Amyloid beta peptides and methods of use |
| US8414927B2 (en) * | 2006-11-03 | 2013-04-09 | Boston Scientific Scimed, Inc. | Cross-linked polymer particles |
| US9000048B2 (en) * | 2006-11-28 | 2015-04-07 | Wisconsin Alumni Research Foundation | Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics |
| KR101475447B1 (ko) * | 2006-12-01 | 2014-12-23 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 자기-조립 블록 코폴리머의 베시클 그리고 그것의 제조 및 사용 방법 |
| WO2008070141A2 (en) * | 2006-12-06 | 2008-06-12 | Wisconsin Alumni Research Foundation | Compositions for delivery of therapeutic agents |
| EP2120913B1 (en) * | 2006-12-22 | 2015-01-21 | NanoPharmaceuticals LLC | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| CA2673622A1 (en) * | 2006-12-22 | 2008-07-03 | Imuthes Limited | Lipid |
| US8900562B2 (en) * | 2007-01-12 | 2014-12-02 | Wisconsin Alumni Research Foundation | Semi-fluorinated block copolymers for delivery of therapeutic agents |
| WO2008089487A2 (en) * | 2007-01-19 | 2008-07-24 | The Cleveland Clinic Foundation | Carboxyethylpyrrole compounds and methods of their production |
| WO2008089485A2 (en) * | 2007-01-19 | 2008-07-24 | The Cleveland Clinic Foundation | Carboxyethylpyrrole compounds and methods of their production |
| US7758635B2 (en) * | 2007-02-13 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical device including cylindrical micelles |
| US20080248097A1 (en) * | 2007-02-26 | 2008-10-09 | Kwon Glen S | Polymeric micelles for combination drug delivery |
| WO2008106657A2 (en) * | 2007-03-01 | 2008-09-04 | Intezyne Technologies, Inc. | Encapsulated amyloid-beta peptides |
| MX2009011479A (es) * | 2007-04-30 | 2010-02-01 | Intezyne Technologies Inc | Micelas de copolimero de bloque hibrido con estereoquimica mezclada para encapsulacion de hidrofobos. |
| WO2008134734A2 (en) * | 2007-04-30 | 2008-11-06 | Intezyne Technologies, Inc. | Encapsulated contrast agents |
| WO2008144475A1 (en) | 2007-05-17 | 2008-11-27 | California Pacific Medical Center | Methods and compositions for treating cancer |
| WO2009061473A2 (en) * | 2007-11-07 | 2009-05-14 | Mallinckrodt Inc. | Photonic shell-core cross linked and functionalized nanostructures for biological applications |
| WO2009073193A2 (en) * | 2007-12-03 | 2009-06-11 | The Johns Hopkins University | Methods of synthesis and use of chemospheres |
| CN101980738A (zh) | 2008-02-07 | 2011-02-23 | 华盛顿大学 | 圆周气雾设备 |
| US20090232762A1 (en) * | 2008-03-11 | 2009-09-17 | May Pang Xiong | Compositions for delivery of therapeutic agents |
| US8034396B2 (en) | 2008-04-01 | 2011-10-11 | Tyco Healthcare Group Lp | Bioadhesive composition formed using click chemistry |
| JP5317031B2 (ja) * | 2008-05-07 | 2013-10-16 | 公立大学法人大阪府立大学 | ヘッド−テイル型共重合体の中空ナノ微粒子 |
| GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| GB2475183B (en) * | 2008-06-04 | 2011-11-23 | Gw Pharma Ltd | Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators |
| CN101808668B (zh) * | 2008-07-29 | 2012-06-27 | 那野伽利阿株式会社 | 药物内包活性靶向型高分子微团、医药组合物 |
| US20110250297A1 (en) * | 2008-09-25 | 2011-10-13 | Oronsky Bryan T | Treatment of Hyperproliferative Disorders Using Cardiac Glycosides |
| CA2738766A1 (en) * | 2008-09-25 | 2010-04-01 | Invivo Therapeutics Corporation | Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents |
| WO2010042823A1 (en) * | 2008-10-09 | 2010-04-15 | Northeastern Universtiy | Multifunctional self-assembling polymeric nanosystems |
| AU2013204152B2 (en) * | 2008-11-06 | 2016-04-14 | Phaserx, Inc. | Multiblock copolymers |
| EP2364330B1 (en) * | 2008-11-06 | 2015-03-25 | University Of Washington | Multiblock copolymers |
| WO2010075332A1 (en) * | 2008-12-23 | 2010-07-01 | Charitable Leadership Foundation | Small molecule ligands of the integrin rgd recognition site and methods of use |
| US9039979B2 (en) | 2009-02-21 | 2015-05-26 | Sofradim Production | Apparatus and method of reacting polymers passing through metal ion chelated resin matrix to produce injectable medical devices |
| US9273191B2 (en) | 2009-02-21 | 2016-03-01 | Sofradim Production | Medical devices with an activated coating |
| US8877170B2 (en) | 2009-02-21 | 2014-11-04 | Sofradim Production | Medical device with inflammatory response-reducing coating |
| CA2753171A1 (en) | 2009-02-21 | 2010-08-26 | Sofradim Production | Crosslinked fibers and method of making same using uv radiation |
| US8956603B2 (en) | 2009-02-21 | 2015-02-17 | Sofradim Production | Amphiphilic compounds and self-assembling compositions made therefrom |
| US8535477B2 (en) | 2009-02-21 | 2013-09-17 | Sofradim Production | Medical devices incorporating functional adhesives |
| US8512728B2 (en) | 2009-02-21 | 2013-08-20 | Sofradim Production | Method of forming a medical device on biological tissue |
| EP2398524B1 (en) | 2009-02-21 | 2017-07-12 | Covidien LP | Medical devices having activated surfaces |
| CA2753179A1 (en) | 2009-02-21 | 2010-08-26 | Sofradim Production | Crosslinked fibers and method of making same by extrusion |
| US8663689B2 (en) | 2009-02-21 | 2014-03-04 | Sofradim Production | Functionalized adhesive medical gel |
| WO2010095052A2 (en) * | 2009-02-21 | 2010-08-26 | Sofradim Production | Compounds and medical devices activated with solvophobic linkers |
| EP2398523B1 (en) | 2009-02-21 | 2018-04-04 | Covidien LP | Medical devices having activated surfaces |
| EP2398584A2 (en) | 2009-02-21 | 2011-12-28 | Sofradim Production | Apparatus and method of reaching polymers by exposure to uv radiation to produce injectable medical devices |
| US8968733B2 (en) | 2009-02-21 | 2015-03-03 | Sofradim Production | Functionalized surgical adhesives |
| US9180107B2 (en) * | 2009-03-31 | 2015-11-10 | Nanopharmaceuticals Llc | Combination treatment of cancer with cetuximab and tetrac |
| WO2010127159A2 (en) * | 2009-04-30 | 2010-11-04 | Intezyne Technologies, Incorporated | Polymeric micelles for polynucleotide encapsulation |
| US8524784B2 (en) * | 2009-04-30 | 2013-09-03 | Intezyne Technologies, Incorporated | Polymer micelles containing anthracylines for the treatment of cancer |
| WO2010127154A1 (en) * | 2009-04-30 | 2010-11-04 | Intezyne Technologies, Incorporated | Polymers for polynucleotide encapsulation |
| WO2010127271A1 (en) * | 2009-04-30 | 2010-11-04 | Intezyne Technologies, Incorporated | Polymer micelles containing anthracylines for the treatment of cancer |
| WO2010129581A1 (en) * | 2009-05-04 | 2010-11-11 | Intezyne Technologies, Incorporated | Polymer micelles containing sn-38 for the treatment of cancer |
| WO2010148007A2 (en) * | 2009-06-17 | 2010-12-23 | Ordway Research Institute, Inc. | Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |
| WO2011038278A2 (en) | 2009-09-25 | 2011-03-31 | Wisconsin Alumni Research Foundation | Micelle encapsulation of therapeutic agents |
| WO2011062965A2 (en) | 2009-11-18 | 2011-05-26 | University Of Washington Through Its Center For Commercialization | Targeting monomers and polymers having targeting blocks |
| WO2011102905A1 (en) * | 2010-02-19 | 2011-08-25 | Robert Shorr | Imageable lipid-oil-water nanoemulsion diagnostic delivery system |
| WO2011102906A1 (en) * | 2010-02-19 | 2011-08-25 | Robert Shorr | Imageable lipid-oil-water nanoemulsion delivery system |
| WO2011102904A1 (en) * | 2010-02-19 | 2011-08-25 | Robert Shorr | Imageable lipid-oil-water nanoemulsion therapeutic delivery system |
| PH12012501596A1 (en) * | 2010-02-24 | 2017-02-03 | Arrowhead Res Corporation | Compositions for targeted delivery of sirna |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| US20110229528A1 (en) * | 2010-03-12 | 2011-09-22 | Intezyne Technologies, Incorporated | Pegylated polyplexes for polynucleotide delivery |
| US8795331B2 (en) | 2010-03-25 | 2014-08-05 | Covidien Lp | Medical devices incorporating functional adhesives |
| CA2794336A1 (en) | 2010-03-25 | 2011-09-29 | Sofradim Production | Surgical fasteners and methods for sealing wounds |
| FR2958649B1 (fr) * | 2010-04-07 | 2012-05-04 | Arkema France | Copolymere a blocs issu de matieres renouvelables et procede de fabrication d'un tel copolymere a blocs |
| EP2571529A2 (en) | 2010-05-14 | 2013-03-27 | Mallinckrodt LLC | Functional, cross-linked nanostructures for tandem optical imaging and therapy |
| EP2588525A4 (en) | 2010-06-29 | 2015-06-10 | Covidien Lp | MICROWAVE POWERED REACTOR AND IN SITU IMPLANT TRAINING METHOD |
| US8865857B2 (en) | 2010-07-01 | 2014-10-21 | Sofradim Production | Medical device with predefined activated cellular integration |
| WO2012018594A2 (en) * | 2010-07-26 | 2012-02-09 | Scott & White Healthcare | Plant-derived polysaccharides for delivery of rna-based therapies |
| WO2012014080A2 (en) | 2010-07-27 | 2012-02-02 | Sofradim Production | Polymeric fibers having tissue reactive members |
| EP2608800B1 (en) | 2010-08-23 | 2017-01-18 | The Regents of The University of California | Compositions and uses of materials with high antimicrobial activity and low toxicity |
| US11414663B2 (en) | 2010-12-01 | 2022-08-16 | Gowey Research Group, Pllc | Micro-RNA profiling, compositions, and methods of treating diseases |
| US10758578B2 (en) | 2010-12-01 | 2020-09-01 | Gowey Research Group PLLC | Herbal formulations of carnivorous plants and methods for treating inflammation |
| US12318420B2 (en) | 2010-12-01 | 2025-06-03 | Gowey Research Group, Pllc | Herbal formulations of carnivorous plants and methods for treating inflammation |
| US11344505B1 (en) | 2010-12-01 | 2022-05-31 | Gowey Research Group, Pllc | Herbal formulations of carnivorous plants and methods for treating inflammation |
| US12606824B2 (en) | 2010-12-01 | 2026-04-21 | Gowey Research Group, Pllc | Micro-RNA profiling, compositions, and methods of treating diseases |
| US10744151B1 (en) * | 2010-12-01 | 2020-08-18 | Gowey Research Group PLLC | Micro-RNA profiling, compositions, and methods of treating diseases |
| GB2487712B (en) | 2011-01-04 | 2015-10-28 | Otsuka Pharma Co Ltd | Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy |
| US8802240B2 (en) | 2011-01-06 | 2014-08-12 | Nanopharmaceuticals Llc | Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
| EP2680913B1 (en) | 2011-03-03 | 2020-05-06 | Impel NeuroPharma Inc. | Nasal drug delivery device |
| US9498533B2 (en) | 2011-04-04 | 2016-11-22 | Board Of Regents Of The University Of Nebraska | Drug delivery compositions and methods |
| WO2012140674A1 (en) | 2011-04-11 | 2012-10-18 | Council Of Scientific & Industrial Research | Surface induced disassembly of nano containers |
| CN107376071B (zh) | 2011-05-09 | 2021-07-09 | 英倍尔药业股份有限公司 | 用于将化合物递送到使用者的上部嗅觉区的喷嘴 |
| US9592302B2 (en) * | 2011-05-23 | 2017-03-14 | University Of Massachusetts | Crosslinked polymer nano-assemblies and uses thereof |
| EP2543685A1 (de) * | 2011-07-08 | 2013-01-09 | cynora GmbH | Verfahren zur kovalenten Bindung eines Metallkomplexes an ein Polymer |
| US8808734B2 (en) * | 2011-07-11 | 2014-08-19 | Full Spectrum Laboratories Limited | Cannabinoid formulations |
| US9901616B2 (en) | 2011-08-31 | 2018-02-27 | University Of Georgia Research Foundation, Inc. | Apoptosis-targeting nanoparticles |
| US8609146B2 (en) | 2011-09-19 | 2013-12-17 | Intezyne Technologies, Inc. | Multi-block copolymers for the preparation of stabilized micelles |
| GB2495118B (en) | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| KR101334420B1 (ko) * | 2011-11-17 | 2013-11-29 | 재단법인대구경북과학기술원 | 약물 전달을 위한 코어 크로스링킹된 고분자 마이셀 화합물 및 이의 제조방법 |
| TWI568453B (zh) * | 2011-11-22 | 2017-02-01 | 原創生醫股份有限公司 | 具有螯合型複合微胞之藥物載體及其應用 |
| ES2923757T3 (es) | 2011-12-16 | 2022-09-30 | Modernatx Inc | Composiciones de ARNm modificado |
| US10416167B2 (en) | 2012-02-17 | 2019-09-17 | University Of Georgia Research Foundation, Inc. | Nanoparticles for mitochondrial trafficking of agents |
| WO2013124867A1 (en) | 2012-02-21 | 2013-08-29 | Amrita Vishwa Vidyapeetham University | Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules |
| DK2634193T3 (en) * | 2012-02-29 | 2015-03-02 | Enzypep B V | Condensation of the side-chain protected oligopeptidfragmenter using subtilisins in organic solvents |
| WO2013151664A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| CN104411338A (zh) | 2012-04-02 | 2015-03-11 | 现代治疗公司 | 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸 |
| US9944752B2 (en) | 2012-04-11 | 2018-04-17 | Intezyne Technologies, Inc. | Block copolymers for stable micelles |
| US20140127271A1 (en) * | 2012-04-11 | 2014-05-08 | Intezyne Technologies, Inc. | Block copolymers for stable micelles |
| US20140113879A1 (en) * | 2012-04-11 | 2014-04-24 | Intezyne Technologies, Inc. | Block copolymers for stable micelles |
| CN106511270A (zh) * | 2012-04-11 | 2017-03-22 | 茵肽锌科技公司 | 用于稳定的胶束的嵌段共聚物 |
| KR101628586B1 (ko) * | 2012-08-28 | 2016-06-08 | (주)오리지날 바이오메디칼스 | 킬레이트 복합 교질입자로 구성된 의약 조성물의 제어방출방법 |
| US20140134601A1 (en) * | 2012-11-09 | 2014-05-15 | Korea University Research And Business Foundation | Use of protein nanoparticle based hydrogel |
| KR101403191B1 (ko) * | 2012-11-19 | 2014-06-02 | 가톨릭대학교 산학협력단 | 약물 전달을 위한 야누스 및 다중 결합 미셀 및 이의 제조 방법 |
| WO2014141289A1 (en) | 2013-03-12 | 2014-09-18 | Amrita Vishwa Vidyapeetham University | Photo - chemo composition on the basis of microcapsules with a core -shell structure |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US10258698B2 (en) | 2013-03-14 | 2019-04-16 | Modernatx, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| US9784730B2 (en) | 2013-03-21 | 2017-10-10 | University Of Washington Through Its Center For Commercialization | Nanoparticle for targeting brain tumors and delivery of O6-benzylguanine |
| CN105492011A (zh) | 2013-04-08 | 2016-04-13 | 丹尼斯·M·布朗 | 不理想给药化学化合物的治疗增效 |
| HK1222358A1 (zh) | 2013-04-28 | 2017-06-30 | Impel Neuropharma Inc. | 医用单位剂量容器 |
| US9775928B2 (en) | 2013-06-18 | 2017-10-03 | Covidien Lp | Adhesive barbed filament |
| GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
| WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| CA2923029A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Chimeric polynucleotides |
| FR3011550B1 (fr) * | 2013-10-07 | 2016-11-18 | Arkema France | Copolymere a blocs polyamide et a bloc polyether |
| US20170080093A1 (en) * | 2013-10-22 | 2017-03-23 | Tyme, Inc. | Tyrosine Derivatives And Compositions Comprising Them |
| US9585841B2 (en) * | 2013-10-22 | 2017-03-07 | Tyme, Inc. | Tyrosine derivatives and compositions comprising them |
| US10060934B2 (en) | 2013-11-18 | 2018-08-28 | Nanopharmaceuticals Llc | Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof |
| SI3071696T1 (sl) | 2013-11-22 | 2019-11-29 | Mina Therapeutics Ltd | C/EBP alfa kratko delujoči RNA sestavki in postopki uporabe |
| US9763992B2 (en) | 2014-02-13 | 2017-09-19 | Father Flanagan's Boys' Home | Treatment of noise induced hearing loss |
| WO2015138992A1 (en) | 2014-03-14 | 2015-09-17 | University Of Georgia Research Foundation, Inc. | Mitochondrial delivery of 3-bromopyruvate |
| US9622970B2 (en) * | 2014-05-08 | 2017-04-18 | Yaguang Liu | Pharmaceutical composition containing lutein and antioxidant for treating and preventing human disease |
| WO2015179402A1 (en) | 2014-05-19 | 2015-11-26 | North Carolina State University | Methods of folding a graft copolymer with dual anticancer drugs and related applications |
| WO2016011226A1 (en) | 2014-07-16 | 2016-01-21 | Moderna Therapeutics, Inc. | Chimeric polynucleotides |
| EP3171895A1 (en) | 2014-07-23 | 2017-05-31 | Modernatx, Inc. | Modified polynucleotides for the production of intrabodies |
| CA2958578A1 (en) | 2014-08-21 | 2016-02-25 | The General Hospital Corporation | Tumor necrosis factor superfamily and tnf-like ligand muteins and methods of preparing and using the same |
| US11298424B2 (en) | 2014-10-01 | 2022-04-12 | The Regents Of The University Of California | Non-ionic and thermoresponsive diblock copolypeptide hydrogels for delivery of molecules and cells |
| CN104448300B (zh) * | 2014-12-09 | 2017-01-11 | 西安医学院 | 低分子量l-聚谷氨酸-丝裂霉素c及其合成方法和应用 |
| US11633355B2 (en) | 2014-12-12 | 2023-04-25 | Clemson University Research Foundation | Multi-functional particles and methods of using the same |
| US10232050B1 (en) | 2014-12-12 | 2019-03-19 | Clemson University | Multi-functional particles and methods of using the same |
| US9956300B2 (en) * | 2015-03-18 | 2018-05-01 | Duke Univerity | Hydrogels formed from polypeptide micelles and methods of use thereof |
| FR3034423B1 (fr) * | 2015-04-03 | 2019-05-31 | Cnrs | Dispersion aqueuse de particules d'au moins un polymere thermoplastique, son procede de preparation et ses applications, notamment pour l'ensimage de fibres de renfort |
| EP3297655B1 (en) | 2015-05-18 | 2020-04-15 | Arizona Board of Regents on Behalf of the University of Arizona | Enhanced melanoma cancer prevention by novel melanotropins |
| JP2018520113A (ja) * | 2015-05-26 | 2018-07-26 | インテザイン テクノロジーズ, インコーポレイテッド | 磁性造影剤としての鉄安定化ミセル |
| EP3341059B1 (en) | 2015-09-10 | 2022-03-02 | Impel NeuroPharma Inc. | In-line nasal delivery device |
| EP3364981A4 (en) | 2015-10-22 | 2019-08-07 | ModernaTX, Inc. | VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS |
| SG11201803360UA (en) | 2015-10-22 | 2018-05-30 | Modernatx Inc | Nucleic acid vaccines for varicella zoster virus (vzv) |
| PE20181531A1 (es) | 2015-10-22 | 2018-09-26 | Modernatx Inc | Vacuna del virus herpes simple |
| US20180271970A1 (en) | 2015-10-22 | 2018-09-27 | Modernatx, Inc. | Respiratory syncytial virus vaccine |
| MA46023A (fr) | 2015-10-22 | 2019-07-03 | Modernatx Inc | Vaccin contre le virus de la grippe à large spectre |
| DE20164728T1 (de) | 2015-10-22 | 2021-09-30 | Modernatx, Inc. | Impfstoffe gegen atemwegsvirus |
| SMT202200310T1 (it) | 2015-12-23 | 2022-09-14 | Modernatx Inc | Metodi di utilizzo dei polinucleotidi codificanti il ligando di ox40 |
| US20190241658A1 (en) | 2016-01-10 | 2019-08-08 | Modernatx, Inc. | Therapeutic mRNAs encoding anti CTLA-4 antibodies |
| KR101905010B1 (ko) | 2016-04-19 | 2018-10-08 | 앱티스 주식회사 | 코엔자임 q10 가용화 조성물 및 이의 제조방법 |
| AU2017279536A1 (en) | 2016-06-07 | 2018-12-20 | Nanopharmaceuticals, Llc | Non-cleavable polymer conjugated with αvβ3 integrin thyroid antagonists |
| US10548908B2 (en) | 2016-09-15 | 2020-02-04 | Nostopharma, LLC | Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification |
| US10143689B2 (en) | 2017-02-08 | 2018-12-04 | Interzyne Technologies, Inc. | SN-38 loaded iron crosslinked micelle and methods thereof |
| CN110591078B (zh) * | 2017-06-26 | 2021-11-05 | 苏州大学 | 还原/pH双重响应性阿霉素前药的制备方法 |
| WO2019048632A1 (en) | 2017-09-08 | 2019-03-14 | Mina Therapeutics Limited | STABILIZED COMPOSITIONS OF SMALL ACTIVATORY RNA (PARNA) OF HNF4A AND METHODS OF USE |
| WO2019048645A1 (en) | 2017-09-08 | 2019-03-14 | Mina Therapeutics Limited | STABILIZED COMPOSITIONS OF SMALL ACTIVATOR RNA (PARNA) FROM CEBPA AND METHODS OF USE |
| ES2974289T3 (es) | 2017-09-28 | 2024-06-26 | Univ California | Hidrogeles de polipéptidos de complejo poliiónico y utilizaciones de los mismos |
| WO2019094702A1 (en) | 2017-11-10 | 2019-05-16 | Cocoon Biotech Inc. | Ocular applications of silk-based products |
| US11571532B2 (en) | 2017-11-21 | 2023-02-07 | Impel Pharmaceuticals Inc. | Intranasal device with dip tube |
| US11395887B2 (en) | 2017-11-21 | 2022-07-26 | Impel Pharmaceuticals Inc. | Intranasal device with inlet interface |
| WO2019113461A1 (en) * | 2017-12-08 | 2019-06-13 | Western University Of Health Sciences | Lipid emulsified drug delivery systems for chemoprevention and treatment |
| WO2019129657A1 (en) | 2017-12-28 | 2019-07-04 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Actively targeted polymeric micelles for drug and gene delivery |
| EP3735223A4 (en) | 2018-01-05 | 2021-10-13 | Impel Neuropharma Inc. | INTRANASAL ADMINISTRATION OF OLANZAPINE BY A PRECISION OLFACTORY DEVICE |
| BR112020013744A8 (pt) | 2018-01-05 | 2022-10-18 | Impel Neuropharma Inc | Dispensação intranasal de di-hidroergotamina por dispositivo olfativo de precisão |
| US10328043B1 (en) | 2018-04-11 | 2019-06-25 | Nanopharmaceuticals, Llc. | Composition and method for dual targeting in treatment of neuroendocrine tumors |
| US11351137B2 (en) | 2018-04-11 | 2022-06-07 | Nanopharmaceuticals Llc | Composition and method for dual targeting in treatment of neuroendocrine tumors |
| US11566246B2 (en) | 2018-04-12 | 2023-01-31 | Mina Therapeutics Limited | SIRT1-saRNA compositions and methods of use |
| CN109111582A (zh) * | 2018-06-14 | 2019-01-01 | 哈尔滨工业大学无锡新材料研究院 | 一种聚醚胺-戊二酸共聚物胶团及其制备方法 |
| JP2021532098A (ja) | 2018-07-19 | 2021-11-25 | インペル ニューロファーマ インコーポレイテッド | パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達 |
| WO2020033791A1 (en) | 2018-08-09 | 2020-02-13 | Verseau Therapeutics, Inc. | Oligonucleotide compositions for targeting ccr2 and csf1r and uses thereof |
| CN113473967B (zh) | 2019-01-03 | 2022-09-09 | 英倍尔制药公司 | 经鼻药物递送装置 |
| EP3953473A1 (en) | 2019-04-12 | 2022-02-16 | MiNA Therapeutics Limited | Sirt1-sarna compositions and methods of use |
| AU2020277313A1 (en) | 2019-05-17 | 2022-01-20 | Impel Pharmaceuticals Inc. | Single-use nasal delivery device |
| KR102376945B1 (ko) * | 2019-12-19 | 2022-03-21 | 상지대학교산학협력단 | 파킨슨병용 약제학적 조성물 및 그 치료제 |
| CN112999151B (zh) * | 2019-12-19 | 2024-03-19 | 鲁南制药集团股份有限公司 | 一种口服用紫杉醇复合胶束 |
| CN113024789B (zh) * | 2019-12-23 | 2023-01-06 | 福建省紫杉园药业有限责任公司 | 一种交联聚合物胶束及其制备方法和应用 |
| CN111228301A (zh) * | 2020-01-14 | 2020-06-05 | 哈尔滨医科大学 | 一种用于治疗血管生成介导疾病的复方制剂及其制备方法和应用 |
| CN111297876B (zh) * | 2020-01-16 | 2021-04-27 | 武汉理工大学 | 一种塞来昔布胶束和和厚朴酚胶束药物联用控释系统及其制备方法 |
| US12090206B2 (en) | 2020-04-23 | 2024-09-17 | The Regents Of The University Of California | Compositions comprising tri- and penta-block synthetic copolypeptide hydrogels |
| US10961204B1 (en) | 2020-04-29 | 2021-03-30 | Nanopharmaceuticals Llc | Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors |
| GB2603454A (en) | 2020-12-09 | 2022-08-10 | Ucl Business Ltd | Novel therapeutics for the treatment of neurodegenerative disorders |
| WO2022145486A1 (en) * | 2020-12-28 | 2022-07-07 | Kawasaki Institute Of Industrial Promotion | Poly-ion complex micelle |
| US20240175033A1 (en) | 2021-03-26 | 2024-05-30 | Mina Therapeutics Limited | TMEM173 saRNA Compositions and Methods of Use |
| KR102701406B1 (ko) * | 2021-10-18 | 2024-08-30 | 재단법인대구경북과학기술원 | 토코페롤을 포함하는 활성 산소 반응형 믹토암 양친매성 화합물, 이의 제조 방법, 및 이를 이용한 약물 전달체 |
| WO2023099884A1 (en) | 2021-12-01 | 2023-06-08 | Mina Therapeutics Limited | Pax6 sarna compositions and methods of use |
| US11723888B2 (en) | 2021-12-09 | 2023-08-15 | Nanopharmaceuticals Llc | Polymer conjugated thyrointegrin antagonists |
| GB202117758D0 (en) | 2021-12-09 | 2022-01-26 | Ucl Business Ltd | Therapeutics for the treatment of neurodegenerative disorders |
| US20250327041A1 (en) | 2022-02-24 | 2025-10-23 | Io Biotech Aps | Nucleotide delivery of cancer therapy |
| WO2023170435A1 (en) | 2022-03-07 | 2023-09-14 | Mina Therapeutics Limited | Il10 sarna compositions and methods of use |
| CN114957733B (zh) * | 2022-05-12 | 2024-04-05 | 安徽工程大学 | Boc-苯丙氨酸改性淀粉纳米粒子及其制备方法和在疏水药物负载的应用 |
| CN114920869B (zh) * | 2022-05-24 | 2023-07-14 | 太原工业学院 | 两亲性精氨酸嵌段环丙沙星共聚物、纳米颗粒及其制备方法和应用 |
| TW202440929A (zh) | 2022-12-14 | 2024-10-16 | 加拿大商普羅維登斯治療控股公司 | 用於感染性疾病的組合物和方法 |
| US20260218178A1 (en) | 2022-12-22 | 2026-07-30 | Mina Therapeutics Limited | Chemically Modified saRNA Compositions and Methods of Use |
| EP4691490A1 (en) | 2023-03-31 | 2026-02-11 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| EP4520345A1 (en) | 2023-09-06 | 2025-03-12 | Myneo Nv | Product |
| WO2026027887A2 (en) | 2024-08-02 | 2026-02-05 | Mina Therapeutics Limited | Hbg1/2-sarna compositions and methods of use |
| WO2026063496A1 (ja) * | 2024-09-19 | 2026-03-26 | 公益財団法人川崎市産業振興財団 | 疎水性分子のためのミセル、および当該ミセルを用いた疎水性分子の送達方法、ならびに当該方法に用いるための疎水性分子を内包したミセルを含む組成物 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2240547A (en) | 1990-01-31 | 1991-08-07 | Ciba Geigy Ag | New compositions |
| KR940003548U (ko) | 1992-08-14 | 1994-02-21 | 김형술 | 세탁물 건조기 |
| BR9610120A (pt) * | 1995-09-07 | 1999-12-21 | Univ Georgia Res Found | Composição farmacêutica e processo para aumentar a meia vida de um medicamento em um indivìduo e para melhorar uma condição patológica em um paciente. |
| JPH11335267A (ja) | 1998-05-27 | 1999-12-07 | Nano Career Kk | 水難溶性薬物を含有するポリマーミセル系 |
| JP4659937B2 (ja) * | 1999-11-19 | 2011-03-30 | ナノキャリア株式会社 | コア−シェル構造のポリイオンコンプレックスミセル |
| JP3523821B2 (ja) | 2000-02-09 | 2004-04-26 | ナノキャリア株式会社 | 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物 |
| FR2814951B1 (fr) | 2000-10-06 | 2003-01-17 | Flamel Tech Sa | Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation |
| FR2822834B1 (fr) | 2001-04-02 | 2005-02-25 | Flamel Tech Sa | Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation |
| US20040126900A1 (en) | 2001-04-13 | 2004-07-01 | Barry Stephen E | High affinity peptide- containing nanoparticles |
| US6881484B2 (en) | 2001-05-30 | 2005-04-19 | Mitsubishi Kagaku Iatron, Inc. | Core-shell particle including signal-generating substance enclosed therein and process for producing the same |
| US20050249786A1 (en) | 2001-09-28 | 2005-11-10 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| US6780324B2 (en) | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
| JP2004010479A (ja) | 2002-06-03 | 2004-01-15 | Japan Science & Technology Corp | ブロック共重合体とアンスラサイクリン系抗癌剤を含む新規固型製剤及びその製造法 |
| JP2004018494A (ja) | 2002-06-19 | 2004-01-22 | Japan Science & Technology Corp | ブロック共重合体−薬剤複合体の製造法 |
| JP4535229B2 (ja) | 2003-05-08 | 2010-09-01 | 国立大学法人 東京大学 | ポリエチレングリコール−ポリカチオンブロック共重合体 |
| JP4763459B2 (ja) | 2003-05-29 | 2011-08-31 | 株式会社東京大学Tlo | 安定化高分子ミセル |
| JP2006199590A (ja) | 2003-09-04 | 2006-08-03 | Nano Career Kk | 水溶性の塩基性薬物内包ナノ粒子含有組成物 |
| US7311901B2 (en) * | 2003-10-10 | 2007-12-25 | Samyang Corporation | Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
| US7612153B2 (en) | 2004-10-25 | 2009-11-03 | Intezyne Technologies, Inc. | Heterobifunctional poly(ethylene glycol) and uses thereof |
| IL165260A0 (en) | 2004-11-16 | 2005-12-18 | Yissum Res Dev Co | Polymeric nano-shells |
| EP1833958A4 (en) | 2005-01-04 | 2009-01-14 | Intezyne Technologies Inc | SYNTHESIS OF HYBRID BLOCK COPOLYMERS AND USES THEREOF |
-
2006
- 2006-04-03 KR KR1020077024561A patent/KR101288729B1/ko not_active Expired - Fee Related
- 2006-04-03 AT AT06749187T patent/ATE440117T1/de not_active IP Right Cessation
- 2006-04-03 ES ES06749187T patent/ES2332062T3/es not_active Expired - Lifetime
- 2006-04-03 MX MX2007012157A patent/MX2007012157A/es active IP Right Grant
- 2006-04-03 US US11/396,872 patent/US7638558B2/en active Active
- 2006-04-03 JP JP2008504516A patent/JP4390845B2/ja not_active Expired - Fee Related
- 2006-04-03 NZ NZ562064A patent/NZ562064A/en not_active IP Right Cessation
- 2006-04-03 DE DE602006008625T patent/DE602006008625D1/de not_active Expired - Lifetime
- 2006-04-03 AU AU2006231452A patent/AU2006231452B2/en not_active Ceased
- 2006-04-03 WO PCT/US2006/012382 patent/WO2006107903A2/en not_active Ceased
- 2006-04-03 CA CA2603853A patent/CA2603853C/en not_active Expired - Fee Related
- 2006-04-03 EP EP06749187A patent/EP1907444B1/en not_active Expired - Lifetime
-
2007
- 2007-09-25 IL IL186254A patent/IL186254A/en active IP Right Grant
-
2009
- 2009-12-22 US US12/644,110 patent/US8263665B2/en active Active
-
2010
- 2010-12-07 US US12/961,918 patent/US8263663B2/en not_active Expired - Lifetime
- 2010-12-07 US US12/962,052 patent/US8299128B2/en active Active
-
2012
- 2012-07-31 US US13/563,118 patent/US8426477B1/en not_active Expired - Fee Related
- 2012-12-19 US US13/720,189 patent/US8779008B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007012157A (es) | 2008-03-14 |
| US20110092668A1 (en) | 2011-04-21 |
| KR101288729B1 (ko) | 2013-07-23 |
| US20100159020A1 (en) | 2010-06-24 |
| CA2603853C (en) | 2013-11-19 |
| CA2603853A1 (en) | 2006-10-12 |
| US20130195987A1 (en) | 2013-08-01 |
| AU2006231452A1 (en) | 2006-10-12 |
| US8299128B2 (en) | 2012-10-30 |
| WO2006107903A2 (en) | 2006-10-12 |
| US7638558B2 (en) | 2009-12-29 |
| US8263663B2 (en) | 2012-09-11 |
| ATE440117T1 (de) | 2009-09-15 |
| US20110091534A1 (en) | 2011-04-21 |
| JP4390845B2 (ja) | 2009-12-24 |
| US8263665B2 (en) | 2012-09-11 |
| US20060240092A1 (en) | 2006-10-26 |
| AU2006231452B2 (en) | 2011-05-26 |
| US8426477B1 (en) | 2013-04-23 |
| JP2008537943A (ja) | 2008-10-02 |
| US8779008B2 (en) | 2014-07-15 |
| KR20080015070A (ko) | 2008-02-18 |
| IL186254A (en) | 2012-04-30 |
| ES2332062T3 (es) | 2010-01-25 |
| EP1907444B1 (en) | 2009-08-19 |
| DE602006008625D1 (de) | 2009-10-01 |
| WO2006107903A3 (en) | 2007-02-15 |
| IL186254A0 (en) | 2008-01-20 |
| EP1907444A2 (en) | 2008-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1907444B1 (en) | Polymeric micelles for drug delivery | |
| AU2008245404B2 (en) | Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents | |
| ES2560235T3 (es) | Copolímeros en bloque para micelas estables | |
| JP2008537943A5 (cg-RX-API-DMAC7.html) | ||
| US20140271885A1 (en) | Copolymers for stable micelle formulations | |
| AU2014256366A1 (en) | Block copolymers for stable micelles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 03 APR 2016 BY COMPUTER PACKAGES INC Effective date: 20130426 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2017 BY COMPUTER PACKAGES INC Effective date: 20160419 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2018 BY COMPUTER PACKAGES INC Effective date: 20170318 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2019 BY COMPUTER PACKAGES INC Effective date: 20180320 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2020 BY COMPUTER PACKAGES INC Effective date: 20190319 |
|
| LAPS | Patent lapsed |